Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the 340B program through “reform.”
columns
2nd District needs a congressman who sides with Mainers, not Trump | Opinion
We need a representative who will stand up to the president when he is wrong. That person would not be Paul LePage.
Why were MaineCare services for children altered without public conversation? | Opinion
Quiet changes could have serious consequences for young people with behavioral health conditions.
To overcome the sins of the past, Maine needs to support Wabanaki rights | Steve Collins
We can’t undo the murder and theft that Maine’s settlers brought to its native population in the past, but we can show respect to the native nations that survived.
Susan Collins has turned her back on women | Opinion
They should send her a reminder at the ballot box this November.
The logistics of care: Nourishing the Midcoast | Opinion
Hunger does not take a day off, even in the scenic towns of Bath and Brunswick. Local organizations and volunteers continue to step up to help those in need.
What Paul Revere and John Hancock would admire about a Maine town meeting | Opinion
I believe this is grassroots democracy at its finest.
Will ranked choice voting be expanded in Maine? | Opinion
The question is before the courts. The system is not without its deficiencies.
For patients throughout Maine, price cap legislation is just what the doctor ordered | Opinion
Families should not be forced to make difficult — even impossible — decisions about whether to buy food and fuel or health insurance.
Maine’s young people are ready to talk politics. Are you? | Opinion
Please trust us to be the capable, critical and motivated citizens we are.